Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
Summary
The CellXpress.ai cell culture system uses automation and AI to maintain this 24/7 schedule, improving workflows and making assays more reliable and reproducible. Integrated machine learning-enabled software facilitates the navigation and monitoring of complex cell culture workflows, including built-in protocols for generating 2D and 3D models. "Last year, we unveiled our partnership with Molecular Devices to create the worlds first fully integrated, high-throughput human cardiac organoid screening solution. With todays official launch of the CellXpress.ai system, we have taken a significant step toward automating HeartBeat.bios proprietary Cardioid technology on this revolutionary platform, making highly-standardized organoids applicable for cardiac drug discovery and cardiotoxicity testing." Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.